Long-term incidence of glioma in Olmsted County, Minnesota, and disparities in postglioma survival rate: a population-based study.

Neuro-oncology Practice
Conor S RyanDaniel H Lachance

Abstract

We assessed glioma incidence and disparities in postglioma survival rate in the Olmsted County, Minnesota, population. This population-based study assessed the incidence of pathologically confirmed primary gliomas between January 1, 1995, and December 31, 2014. Age- and sex-adjusted incidence rates per 100 000 person-years were calculated and standardized to the US white 2010 population. We compared incidence trends of glioma during our study period with previously published Olmsted County data from 1950 to 1990. We assessed postglioma survival rates among individuals with different socioeconomic status (SES), which was measured by a validated individual HOUsing-based SES index (HOUSES). We identified 135 incident glioma cases (93% white) with 20 pediatric (50% female) and 115 adult cases (44% female). Overall incidence rate during our study period, 5.51 per 100 000 person-years (95% CI: 4.56-6.46), showed no significant changes and was similar to that seen in 1950 to 1990, 5.5 per 100 000 person-years. The incidence of pediatric (age < 20 years) glioma was 2.49 (95% CI: 1.40-3.58), whereas adult glioma incidence was 6.47 (95% CI: 5.26-7.67). Among those with grade II to IV gliomas, individuals with lower SES (< median HOUSES) ...Continue Reading

References

Jan 1, 1982·Annals of the New York Academy of Sciences·L T KurlandC A Molgaard
Jan 1, 1995·Annals of Neurology·K RadhakrishnanL T Kurland
Aug 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·C E CounsellR Grant
Dec 16, 2000·Journal of Neurosurgery·B P McKinleyR J Plunkett
Feb 1, 2003·Social Science & Medicine·J Michael Oakes, Peter H Rossi
Oct 12, 2004·Cancer·Kenneth R HessMelissa L Bondy
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Apr 29, 2006·Acta Oncologica·M P W A HoubenJ W W Coebergh
Apr 13, 2007·The New England Journal of Medicine·Florence Keime-GuibertUNKNOWN Association of French-Speaking Neuro-Oncologists
Feb 9, 2008·Neuroepidemiology·Bridget J McCarthyPeter C Burger
Jun 26, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Hamish AlexanderMartin Hunn
Apr 19, 2011·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Young J JuhnArthur R Williams
May 4, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Kathryn M FieldMark A Rosenthal
May 25, 2013·Asia-Pacific Journal of Clinical Oncology·Kathryn Maree FieldKate Drummond
Jun 19, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Y SiaK Drummond
Jan 29, 2014·Neuro-oncology·Emily A J SehmerAdèle C Green
Jun 27, 2014·NPJ Primary Care Respiratory Medicine·Malinda N HarrisYoung J Juhn
Nov 15, 2014·International Journal of Environmental Research and Public Health·Duk Won BangYoung J Juhn
Oct 16, 2015·Journal of Epidemiology and Community Health·Paul Y TakahashiYoung J Juhn
Jan 8, 2016·The Journal of Allergy and Clinical Immunology·Hyo Jin KwonYoung J Juhn
Mar 16, 2017·The New England Journal of Medicine·James R PerryUNKNOWN Trial Investigators
Jun 27, 2017·Annals of Epidemiology·Euijung RyuPaul Y Takahashi
Jun 18, 2019·Cancer·David J CoteJill S Barnholtz-Sloan

❮ Previous
Next ❯

Citations

Nov 14, 2021·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Mahboubeh Fereidan-EsfahaniWilliam Oliver Tobin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.